Chowdhary Covers Risk-Reducing Strategies and Recommendations During the COVID-19 Era

Mudit Chowdhary, MD, shares advice for family members living with patients with cancer, projects the long-term implications of the COVID-19 pandemic on clinical practice, provides insight on the effects of investigational treatments for patients with COVID-19, and details the protocols Rush University Medical Center has put into place to limit the spread of the virus.

Welcome to a very special edition of OncLive® On Air! I’m your host today, Caroline Seymour.

OncLive® On Air is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.

Today, we had the pleasure of speaking with Mudit Chowdhary, MD, to discuss the risk the coronavirus disease 2019 (COVID-19) poses to patients with cancer, recommendations regarding the use of personal protective equipment, the steps that are being taken to ensure the delivery of optimal care, and the rise of telehealth as a means of patient and physician interaction.

In our exclusive interview, Dr. Chowdhary, a chief resident physician of Radiation Oncology at Rush University Medical Center, shared advice for family members living with patients with cancer, projected the long-term implications of the COVID-19 pandemic on clinical practice, provided insight on the effects of investigational treatments for patients with COVID-19, and detailed the protocols Rush University Medical Center has put into place to limit the spread of the virus.

Related Videos
Muhammad Bilal Abid, MD, MRCP
M. Patricia Rivera, MD
Andrea Borondy Kitts
Jacob Sands, MD
Sandip Patel, MD
James L. Mulshine, MD
Zev A. Wainberg, MD, of Jonsson Comprehensive Cancer Center
Chris Labaki, MD, of Dana-Farber Cancer Institute
Quoc-Dien Trinh, MD, of Brigham and Women's Hospital
Renold Capocasale, CEO and founder of FlowMetric, and Grant Morgan, PhD, PMP
Related Content